Medical Elastomers Market - Global Forecast To 2029
商品番号 : SMB-70451
| 出版社 | MarketsandMarkets |
| 出版年月 | 2024年12月 |
| ページ数 | 333 |
| 図表数 | 331 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
Report Overview
The medical elastomer market is projected to reach USD 14.27 billion by 2029 from USD 9.57 billion in 2024, at a CAGR of 8.3%. Growing demand for medical devices is fueling the demand for medical elastomers worldwide.
医療用エラストマー市場は、CAGR 8.3%で、2024年の95億7,000万米ドルから2029年までに142億7,000万米ドルに達すると予測されています。医療機器の需要の高まりにより、世界中で医療用エラストマーの需要が高まっています。
This is a result of the increased use in disposable medical equipment, such as syringes, valves, tubing, and critical implants; artificial heart valves and artificial joints. These materials are versatile, offering durability, biocompatibility, and flexibility, making them suitable in a wide range of medical applications, such as medical tubes, bags, and gloves. The growing healthcare costs in developing economies coupled with technology advancements will further fuel the increasing demand for these critical commodities, rendering them even more indispensable to meet growing healthcare needs across the world. Additionally, the expanding population in emerging economies along with the rising prevalence of chronic diseases is creating a demand for medical elastomers.
“Based on application, implants are the fastest growing application in medical elastomer market during the forecast period, in terms of value.”
Implants are the fastest growing application of medical elastomers due to increasing demand for biocompatible, durable and flexible materials in medical procedures. The rising prevalence of chronic diseases and aging populations are driving the need of durable implants in medical elastomers, as it provides superior orthopedic, dental, and soft tissue implant performance. Flexibility and comfort with least complications further make them appealing. Moreover, the ability of elastomers to be molded into complex shapes and the excellent biocompatibility enhances the future applications of customized implants, thereby further fueling the demand for medical elastomers.
“Based on end-use industry, hospitals & clinics account the largest share in medical elastomer market during the forecast period, in terms of value.”
Hospitals and clinics account for the largest share in the medical elastomer market due to their heavy dependence on medical devices and equipment that utilize elastomer materials. These institutions need a wide range of products based on medical elastomers such as catheters, medical tubing, seals, gaskets, surgical gloves, and implants, in order to ensure appropriate patient care and treatment. However, the growing need for healthcare services due to growing ageing population and rising prevalence of chronic diseases such as diabetes, cardiovascular diseases, and respiratory disorders further boosts the demand for these medical devices. The properties of medical elastomers such as biocompatibility and excellent flexibility & durability along with chemical resistance makes them highly functional for various applications in hospital and clinic applications. These factors, along with the stringent regulatory requirements from healthcare authorities like FDA, ensure that hospitals and clinics are adopting high-quality elastomer-based products. All these factors combined strong healthcare needs, adherence to regulatory requirements, and the drive for advanced, reliable medical devices ensure make hospitals & clinics account largest market share by industry in the medical elastomer market.
“Based on region, Asia Pacific accounts the second largest market for medical elastomer, in terms of value.”
Asia Pacific accounts the second largest market for medical elastomers because of various factors such as economic development, rapid population growth, a good healthcare sector, and increasing demand for medical devices. The rise in investments for healthcare infrastructure in emerging economies like China and India is driving the demand for adoption high-quality medical elastomers into healthcare equipments such as medical tubing, implants, and diagnostic equipment. Large and aging population in the region have added up to this demand as prevalence of chronic diseases is rising among this population. Asia Pacific is, therefore, a growth product concerning medical facility organizations dedicated to better healthcare access, positioning it as a major player in the global medical elastomer market.
In the process of determining and verifying the market size for several segments and subsegments identified through secondary research, extensive primary interviews were conducted. A breakdown of the profiles of the primary interviewees are as follows:
- By Company Type: Tier 1 – 40%, Tier 2 – 30%, and Tier 3 – 30%
- By Designation: Directors- 35%, Managers – 25%, and Others – 40%
- By Region: North America – 22%, Europe – 22%, Asia Pacific – 45%, RoW – 11%
The key players in this market are BASF (Germany), Dow (US), Celanese Corporation (US), Eastman Chemical Company (US), Syensqo (Belgium), Mitsubishi Chemical Group Corporation (Japan), Kuraray Co., Ltd. (Japan), ExxonMobil (US), Momentive Performance Materials (US), Envalior (Germany) and Zeon Corporation (Japan).
Research Coverage
This report segments the medical elastomer market based on type, technology, application, end-use industry, and region, and provides estimations for the overall value of the market across various regions. A detailed analysis of key industry players has been conducted to provide insights into their business overviews, products and services, key strategies, new product launches, expansions, and mergers and acquisitions associated with the medical elastomer market.
Key benefits of buying this report
This research report focuses on various levels of analysis, including industry analysis (industry trends), market ranking analysis of top players, and company profiles, which together provide an overall view of the competitive landscape, emerging and high-growth segments of the medical elastomer market, high-growth regions, and market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
- Analysis of key drivers (Growing demand for medical devices, Technological advancements in healthcare and Prevalence of chronic diseases), restraints (High production costs), opportunities (Growing healthcare investment in emerging economies) and challenges (Stringent regulatory requirements).
- Market Penetration: Comprehensive information on the medical elastomer market offered by top players in the global medical elastomer market.
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the medical elastomer market.
- Market Development: Comprehensive information about lucrative emerging markets — the report analyzes the markets for medical elastomer market across regions.
- Market Diversification: Exhaustive information about new products, untapped regions, and recent developments in the global medical elastomer market
- Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of leading players in the medical elastomer market
Table of Contents
1 INTRODUCTION 26
1.1 STUDY OBJECTIVES 26
1.2 MARKET DEFINITION 26
1.3 STUDY SCOPE 27
1.3.1 MARKETS COVERED AND REGIONAL SCOPE 27
1.3.2 INCLUSIONS AND EXCLUSIONS 28
1.3.3 YEARS CONSIDERED 28
1.4 CURRENCY CONSIDERED 28
1.5 UNITS CONSIDERED 28
1.6 STAKEHOLDERS 29
1.7 SUMMARY OF CHANGES 29
2 RESEARCH METHODOLOGY 30
2.1 RESEARCH DATA 30
2.1.1 SECONDARY DATA 31
2.1.1.1 List of key secondary sources 31
2.1.1.2 Key data from secondary sources 31
2.1.2 PRIMARY DATA 32
2.1.2.1 Key data from primary sources 32
2.1.2.2 List of key primary interview participants 33
2.1.2.3 Key industry insights 33
2.1.2.4 Breakdown of interviews with experts 33
2.2 MARKET SIZE ESTIMATION 34
2.2.1 BOTTOM-UP APPROACH 34
2.2.2 TOP-DOWN APPROACH 35
2.3 GROWTH FORECAST 36
2.4 DATA TRIANGULATION 37
2.5 FACTOR ANALYSIS 38
2.6 RESEARCH ASSUMPTIONS 38
2.7 RESEARCH LIMITATIONS AND RISK ANALYSIS 39
3 EXECUTIVE SUMMARY 40
4 PREMIUM INSIGHTS 44
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN MEDICAL ELASTOMERS MARKET 44
4.2 MEDICAL ELASTOMERS MARKET, BY TYPE, 2024 VS. 2029 (KILOTON) 44
4.3 MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024 VS. 2029 (KILOTON) 45
4.4 MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2024 VS. 2029 (KILOTON) 45
4.5 MEDICAL ELASTOMERS MARKET, BY KEY COUNTRY 46
5 MARKET OVERVIEW 47
5.1 INTRODUCTION 47
5.2 MARKET DYNAMICS 47
5.2.1 DRIVERS 48
5.2.1.1 Growing demand for medical devices 48
5.2.1.2 Technological advancements in healthcare 48
5.2.1.3 Prevalence of chronic diseases 49
5.2.2 RESTRAINTS 49
5.2.2.1 High production costs 49
5.2.3 OPPORTUNITIES 50
5.2.3.1 Growing healthcare investments in emerging economies 50
5.2.3.2 Increasing use in minimally invasive devices 50
5.2.4 CHALLENGES 50
5.2.4.1 Stringent regulatory requirements 50
5.3 PORTER’S FIVE FORCES ANALYSIS 51
5.3.1 THREAT FROM NEW ENTRANTS 52
5.3.2 THREAT OF SUBSTITUTES 52
5.3.3 BARGAINING POWER OF SUPPLIERS 52
5.3.4 BARGAINING POWER OF BUYERS 53
5.3.5 INTENSITY OF COMPETITIVE RIVALRY 53
5.4 KEY STAKEHOLDERS AND BUYING CRITERIA 54
5.4.1 KEY STAKEHOLDERS IN BUYING PROCESS 54
5.4.2 BUYING CRITERIA 55
5.5 MACROECONOMIC OUTLOOK 56
5.5.1 GDP TRENDS AND FORECASTS 56
5.6 IMPACT OF AI/GENAI 59
5.7 VALUE CHAIN ANALYSIS 60
5.8 ECOSYSTEM ANALYSIS 61
5.9 CASE STUDY ANALYSIS 62
5.9.1 KENT ELASTOMERS HELPED IN TRANSITIONING TO NON-LATEX MEDICAL COMPONENTS 62
5.9.2 COOPER UNIVERSITY HOSPITAL BOOSTS POLYPHENYLENE ETHER RESILIENCE WITH DENTEC SAFETY COMFORT-AIRNXMD 63
5.9.3 TECNOFLON FKM AS HIGH-PERFORMANCE ALTERNATIVE TO SILICONE IN ORTHOPEDIC APPLICATIONS 63
5.10 REGULATORY LANDSCAPE 64
5.10.1 ENVIRONMENTAL REGULATIONS 64
5.10.2 NORTH AMERICA 64
5.10.3 ASIA PACIFIC 65
5.10.4 EUROPE 66
5.10.5 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 67
5.11 TECHNOLOGY ANALYSIS 68
5.11.1 KEY TECHNOLOGIES 68
5.11.1.1 Extrusion technology 68
5.11.1.2 Compression molding 68
5.11.2 COMPLEMENTARY TECHNOLOGIES 68
5.11.2.1 Co-extrusion technology 68
5.11.3 ADJACENT TECHNOLOGIES 69
5.11.3.1 Additive manufacturing technology 69
5.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 69
5.13 TRADE ANALYSIS 70
5.13.1 IMPORT SCENARIO (HS CODE 391000) 70
5.13.2 EXPORT SCENARIO (HS CODE 391000) 71
5.13.3 IMPORT SCENARIO (HS CODE 400270) 72
5.13.4 EXPORT SCENARIO (HS CODE 400270) 73
5.14 KEY CONFERENCES AND EVENTS, 2024–2025 74
5.15 PRICING ANALYSIS 75
5.15.1 AVERAGE SELLING PRICE TREND OF MEDICAL ELASTOMERS, BY REGION 75
5.15.2 AVERAGE SELLING PRICE TREND OF MEDICAL ELASTOMERS,
BY APPLICATION 76
5.15.3 AVERAGE SELLING PRICE TREND OF MEDICAL ELASTOMERS,
BY END-USE INDUSTRY 76
5.16 INVESTMENT AND FUNDING SCENARIO 77
5.17 PATENT ANALYSIS 77
5.17.1 INTRODUCTION 77
5.17.2 LEGAL STATUS OF PATENTS 79
5.17.3 JURISDICTION ANALYSIS 80
5.18 LIST OF POTENTIAL CUSTOMERS 80
6 MEDICAL ELASTOMERS MARKET, BY TECHNOLOGY 83
6.1 INTRODUCTION 84
6.2 EXTRUSION 84
6.3 INJECTION MOLDING 84
6.4 COMPRESSION MOLDING 84
6.5 OTHER TECHNOLOGIES 85
7 MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY 86
7.1 INTRODUCTION 87
7.2 HOSPITALS & CLINICS 89
7.2.1 RISING PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET 89
7.3 PHARMACEUTICAL 89
7.3.1 CRUCIAL ROLE OF ELASTOMERS IN PACKAGING AND DRUG DELIVERY SYSTEMS TO PROPEL ADOPTION 89
7.4 MEDICAL DEVICE MANUFACTURING 90
7.4.1 RISING DEMAND FOR ADVANCED MEDICAL DEVICES TO SUPPORT MARKET GROWTH 90
7.5 OTHER END-USE INDUSTRIES 90
8 MEDICAL ELASTOMERS MARKET, BY APPLICATION 91
8.1 INTRODUCTION 92
8.2 MEDICAL TUBING 96
8.2.1 HIGH CONSUMPTION IN ADVANCING MEDICAL TUBING SOLUTIONS TO DRIVE MARKET 96
8.3 CATHETERS 97
8.3.1 VITAL ROLE IN PRODUCTION OF CATHETERS TO PROPEL GROWTH 97
8.4 GLOVES 97
8.4.1 INCREASING NEED FOR PERSONAL PROTECTIVE EQUIPMENT TO INCREASE DEMAND 97
8.5 SYRINGES 97
8.5.1 PRE-FILLED SYRINGES 98
8.5.1.1 Reduce risk of dosing errors—key factor driving adoption 98
8.5.2 NON-PRE-FILLED SYRINGES 98
8.5.2.1 Increasing incidence of chronic diseases to propel adoption 98
8.5.3 VIALS 98
8.5.3.1 Increasing need for safe and effective drug delivery systems to drive market 98
8.6 MEDICAL & INFUSION BAGS 99
8.6.1 RISE IN HOSPITAL-ACQUIRED INFECTIONS TO SUPPORT MARKET GROWTH 99
8.7 IMPLANTS 99
8.7.1 INCREASING PREVALENCE OF AGE-RELATED HEALTH CONDITIONS TO DRIVE MARKET 99
8.8 OTHER APPLICATIONS 100
9 MEDICAL ELASTOMERS MARKET, BY TYPE 101
9.1 INTRODUCTION 102
9.2 THERMOSET ELASTOMERS 104
9.2.1 SILICONE 104
9.2.1.1 Efficient alternative to latex products in medical and pharmaceutical applications 104
9.2.1.2 High temperature vulcanized 105
9.2.1.3 Liquid silicone rubber 105
9.2.1.4 Room temperature vulcanized 105
9.2.2 ETHYLENE PROPYLENE DIENE MONOMER 106
9.2.2.1 Suitable for various medical applications—key factor supporting market growth 106
9.2.3 OTHER THERMOSET ELASTOMERS 106
9.3 THERMOPLASTIC ELASTOMERS 106
9.3.1 THERMOPLASTIC POLYURETHANE 107
9.3.1.1 Provide efficiency in manufacturing complex designs using extrusion and molding techniques 107
9.3.2 STYRENE BLOCK COPOLYMERS 107
9.3.2.1 Biostability of SBC increases utility in medical applications—key factor driving market growth 107
9.3.3 OTHER THERMOPLASTIC ELASTOMERS 107
10 MEDICAL ELASTOMERS MARKET, BY REGION 108
10.1 INTRODUCTION 109
10.2 NORTH AMERICA 111
10.2.1 US 121
10.2.1.1 Rising healthcare spending to drive market 121
10.2.2 CANADA 124
10.2.2.1 Expanding healthcare system to support market growth 124
10.2.3 MEXICO 128
10.2.3.1 Government initiatives and growth of healthcare sector to drive market 128
10.3 ASIA PACIFIC 132
10.3.1 CHINA 142
10.3.1.1 Growing aging population to drive market 142
10.3.2 JAPAN 145
10.3.2.1 Increased focus on infection control and patient safety to propel market 145
10.3.3 INDIA 149
10.3.3.1 Increasing investments in healthcare sector to drive market 149
10.3.4 SOUTH KOREA 153
10.3.4.1 Rising demand for high quality medical devices to drive market 153
10.3.5 INDONESIA 157
10.3.5.1 Rising incidence of chronic diseases to drive market 157
10.3.6 REST OF ASIA PACIFIC 161
10.4 EUROPE 165
10.4.1 GERMANY 175
10.4.1.1 Increased investments in R&D to drive market 175
10.4.2 UK 178
10.4.2.1 Rising geriatric population to support market growth 178
10.4.3 FRANCE 182
10.4.3.1 Presence of significant medical device manufacturers to propel market 182
10.4.4 ITALY 186
10.4.4.1 Rising demand for medical devices from public hospitals to increase demand 186
10.4.5 SPAIN 190
10.4.5.1 Increasing investments in healthcare infrastructure to propel market 190
10.4.6 REST OF EUROPE 194
10.5 MIDDLE EAST & AFRICA 198
10.5.1 GCC COUNTRIES 207
10.5.1.1 Saudi Arabia 207
10.5.1.1.1 Need for advanced medical technologies to drive market 207
10.5.1.2 Rest of GCC countries 211
10.5.2 SOUTH AFRICA 215
10.5.2.1 Outbreak of contagious diseases to drive market 215
10.5.3 REST OF MIDDLE EAST & AFRICA 219
10.6 SOUTH AMERICA 223
10.6.1 BRAZIL 232
10.6.1.1 Largest market for medical elastomers in South America 232
10.6.2 ARGENTINA 235
10.6.2.1 Growing demand for medical devices to drive market 235
10.6.3 REST OF SOUTH AMERICA 239
11 COMPETITIVE LANDSCAPE 244
11.1 OVERVIEW 244
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2019–2024 245
11.3 REVENUE ANALYSIS, 2021–2023 246
11.4 MARKET SHARE ANALYSIS, 2023 247
11.4.1 NORTH AMERICA: MARKET SHARE ANALYSIS, BY APPLICATION, 2023 248
11.4.2 EUROPE: MARKET SHARE ANALYSIS, BY APPLICATION, 2023 249
11.4.3 ASIA PACIFIC: MARKET SHARE ANALYSIS, BY APPLICATION, 2023 250
11.4.4 DOW 250
11.4.5 EXXON MOBIL CORPORATION 251
11.4.6 CELANESE CORPORATION 251
11.4.7 BASF 251
11.4.8 WACKER CHEMIE AG 251
11.5 COMPANY VALUATION AND FINANCIAL METRICS 252
11.6 BRAND/PRODUCT COMPARISON 253
11.6.1 MEDICAL ELASTOMERS MARKET: BRAND/PRODUCT COMPARISON ANALYSIS 253
11.6.2 ELASTOLLAN 253
11.6.3 ENGAGE 8480K HEALTH+ 253
11.6.4 HYTREL 254
11.6.5 ECDEL 254
11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 254
11.7.1 STARS 254
11.7.2 EMERGING LEADERS 254
11.7.3 PERVASIVE PLAYERS 254
11.7.4 PARTICIPANTS 254
11.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 256
11.7.5.1 Overall company footprint 256
11.7.5.2 Region footprint 257
11.7.5.3 Technology footprint 258
11.7.5.4 Type Footprint 259
11.7.5.5 Application footprint 260
11.7.5.6 Industry footprint 261
11.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 262
11.8.1 PROGRESSIVE COMPANIES 262
11.8.2 RESPONSIVE COMPANIES 262
11.8.3 DYNAMIC COMPANIES 262
11.8.4 STARTING BLOCKS 262
11.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 264
11.8.5.1 Detailed list of startups/SMEs 264
11.8.5.2 Competitive benchmarking of startups/SMEs 265
11.9 COMPETITIVE SCENARIO 267
11.9.1 PRODUCT LAUNCHES 267
11.9.2 DEALS 268
11.9.3 EXPANSIONS 269
11.9.4 OTHER DEVELOPMENTS 270
12 COMPANY PROFILES 271
12.1 KEY PLAYERS 271
12.1.1 DOW 271
12.1.1.1 Business overview 271
12.1.1.2 Products offered 272
12.1.1.3 Recent developments 273
12.1.1.3.1 Other developments 273
12.1.1.4 MnM view 273
12.1.1.4.1 Key strengths 273
12.1.1.4.2 Strategic choices 273
12.1.1.4.3 Weaknesses and competitive threats 274
12.1.2 EXXON MOBIL CORPORATION 274
12.1.2.1 Business overview 274
12.1.2.2 Products offered 276
12.1.2.3 MnM view 276
12.1.2.3.1 Key strengths 276
12.1.2.3.2 Strategic choices 276
12.1.2.3.3 Weaknesses and competitive threats 276
12.1.3 CELANESE CORPORATION 277
12.1.3.1 Business overview 277
12.1.3.2 Products offered 278
12.1.3.3 Recent developments 279
12.1.3.3.1 Deals 279
12.1.3.4 MnM view 280
12.1.3.4.1 Key strengths 280
12.1.3.4.2 Strategic choices 280
12.1.3.4.3 Weaknesses and competitive threats 280
12.1.4 BASF 281
12.1.4.1 Business overview 281
12.1.4.2 Products offered 282
12.1.4.3 Recent developments 283
12.1.4.3.1 Expansions 283
12.1.4.4 MnM view 283
12.1.4.4.1 Key strengths 283
12.1.4.4.2 Strategic choices 284
12.1.4.4.3 Weaknesses and competitive threats 284
12.1.5 WACKER CHEMIE AG 285
12.1.5.1 Business overview 285
12.1.5.2 Products offered 286
12.1.5.3 Recent developments 287
12.1.5.3.1 Product launches 287
12.1.5.3.2 Expansions 288
12.1.5.4 MnM view 289
12.1.5.4.1 Key strengths 289
12.1.5.4.2 Strategic choices 289
12.1.5.4.3 Weaknesses and competitive threats 289
12.1.6 EASTMAN CHEMICAL COMPANY 290
12.1.6.1 Business overview 290
12.1.6.2 Products offered 291
12.1.6.3 MnM view 291
12.1.6.3.1 Key strengths 291
12.1.6.3.2 Strategic choices 292
12.1.6.3.3 Weaknesses and competitive threats 292
12.1.7 SYENSQO 293
12.1.7.1 Business overview 293
12.1.7.2 Products offered 294
12.1.7.3 Recent developments 295
12.1.7.3.1 Other developments 295
12.1.7.4 MnM view 295
12.1.7.4.1 Key strengths 295
12.1.7.4.2 Strategic choices 295
12.1.7.4.3 Weaknesses and competitive threats 296
12.1.8 KURARAY CO., LTD 297
12.1.8.1 Business overview 297
12.1.8.2 Products offered 298
12.1.8.3 MnM view 299
12.1.8.3.1 Key strengths 299
12.1.8.3.2 Strategic choices 299
12.1.8.3.3 Weaknesses and competitive threats 299
12.1.9 MITSUBISHI CHEMICAL GROUP CORPORATION 300
12.1.9.1 Business overview 300
12.1.9.2 Products offered 301
12.1.9.3 Recent developments 302
12.1.9.3.1 Other developments 302
12.1.9.3.2 Deals 303
12.1.9.4 MnM view 303
12.1.10 MOMENTIVE PERFORMANCE MATERIALS 304
12.1.10.1 Business overview 304
12.1.10.2 Products offered 304
12.1.10.3 MnM view 305
12.1.11 ENVALIOR 306
12.1.11.1 Business overview 306
12.1.11.2 Products offered 306
12.1.12 ZEON CORPORATION 308
12.1.12.1 Business overview 308
12.1.12.2 Products offered 309
12.1.13 THE LUBRIZOL CORPORATION 310
12.1.13.1 Business overview 310
12.1.13.2 Products offered 310
12.1.13.3 MnM view 311
12.2 OTHER PLAYERS 312
12.2.1 KRATON CORPORATION 312
12.2.2 FOSTER CORPORATION 313
12.2.3 BIOMERICS 314
12.2.4 RTP COMPANY 315
12.2.5 ROMAR ENGINEERING 316
12.2.6 THE RUBBER GROUP 317
12.2.7 KENT ELASTOMER PRODUCTS 318
12.2.8 RAUMEDIC AG 319
12.2.9 THE HYGENIC COMPANY, LLC 320
12.2.10 HEXAPOL AB 321
12.2.11 TEKNI-PLEX, INC 322
12.2.12 TRINSEO 323
12.2.13 TRELLEBORG AB 324
12.2.14 SAINT-GOBAIN 325
13 APPENDIX 326
13.1 DISCUSSION GUIDE 326
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 329
13.3 CUSTOMIZATION OPTIONS 331
13.4 RELATED REPORTS 331
13.5 AUTHOR DETAILS 332
LIST OF TABLES
TABLE 1 US: CONSUMER MEDICAL DEVICES SALES, 2021–2023 (USD MILLION) 48
TABLE 2 MEDICAL ELASTOMERS MARKET: PORTER’S FIVE FORCES ANALYSIS 53
TABLE 3 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP-THREE END–
USE INDUSTRIES 54
TABLE 4 KEY BUYING CRITERIA FOR TOP-THREE END-USE INDUSTRIES 55
TABLE 5 PROJECTED REAL GDP GROWTH (ANNUAL PERCENTAGE CHANGE) OF KEY COUNTRIES, 2019–2023 56
TABLE 6 GDP ANNUAL PERCENTAGE CHANGE AND PROJECTION OF KEY COUNTRIES,
2024–2029 57
TABLE 7 HEALTH EXPENDITURE AS PERCENTAGE OF GDP, 2019–2022 58
TABLE 8 MEDICAL ELASTOMERS MARKET: ROLE OF PLAYERS IN ECOSYSTEM 62
TABLE 9 MEDICAL ELASTOMERS MARKET: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 67
TABLE 10 IMPORT DATA FOR HS CODE 391000-COMPLIANT PRODUCTS, BY COUNTRY, 2019–2023 (USD THOUSAND) 70
TABLE 11 EXPORT DATA FOR HS CODE 391000-COMPLIANT PRODUCTS, BY COUNTRY, 2019–2023 (USD THOUSAND) 71
TABLE 12 IMPORT DATA FOR HS CODE 400270-COMPLIANT PRODUCTS, BY COUNTRY, 2019–2023 (USD THOUSAND) 72
TABLE 13 EXPORT DATA FOR HS CODE 400270-COMPLIANT PRODUCTS, BY COUNTRY, 2019–2023 (USD THOUSAND) 73
TABLE 14 MEDICAL ELASTOMERS MARKET: KEY CONFERENCES AND EVENTS, 2024–2025 74
TABLE 15 LIST OF PATENTS, 2024 78
TABLE 16 LIST OF POTENTIAL CUSTOMERS 80
TABLE 17 MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2021–2023 (KILOTON) 87
TABLE 18 MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2024–2029 (KILOTON) 88
TABLE 19 MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY,
2021–2023 (USD MILLION) 88
TABLE 20 MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY,
2024–2029 (USD MILLION) 88
TABLE 21 MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (KILOTON) 93
TABLE 22 MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (KILOTON) 94
TABLE 23 MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 95
TABLE 24 MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 96
TABLE 25 MEDICAL ELASTOMERS MARKET, BY TYPE, 2021–2023 (KILOTON) 102
TABLE 26 MEDICAL ELASTOMERS MARKET, BY TYPE, 2024–2029 (KILOTON) 103
TABLE 27 MEDICAL ELASTOMERS MARKET, BY TYPE, 2021–2023 (USD MILLION) 103
TABLE 28 MEDICAL ELASTOMERS MARKET, BY TYPE, 2024–2029 (USD MILLION) 104
TABLE 29 MEDICAL ELASTOMERS MARKET, BY REGION, 2021–2023 (KILOTON) 110
TABLE 30 MEDICAL ELASTOMERS MARKET, BY REGION, 2024–2029 (KILOTON) 110
TABLE 31 MEDICAL ELASTOMERS MARKET, BY REGION, 2021–2023 (USD MILLION) 110
TABLE 32 MEDICAL ELASTOMERS MARKET, BY REGION, 2024–2029 (USD MILLION) 111
TABLE 33 NORTH AMERICA: MARKET SHARES OF DIFFERENT TYPES OF MEDICAL ELASTOMERS, BY APPLICATION, 2023 113
TABLE 34 NORTH AMERICA: MEDICAL ELASTOMERS MARKET, BY COUNTRY,
2021–2023 (KILOTON) 113
TABLE 35 NORTH AMERICA: MEDICAL ELASTOMERS MARKET, BY COUNTRY,
2024–2029 (KILOTON) 113
TABLE 36 NORTH AMERICA: MEDICAL ELASTOMERS MARKET, BY COUNTRY,
2021–2023 (USD MILLION) 113
TABLE 37 NORTH AMERICA: MEDICAL ELASTOMERS MARKET, BY COUNTRY,
2024–2029 (USD MILLION) 114
TABLE 38 NORTH AMERICA: MEDICAL ELASTOMERS MARKET, BY TYPE,
2021–2023 (KILOTON) 114
TABLE 39 NORTH AMERICA: MEDICAL ELASTOMERS MARKET, BY TYPE,
2024–2029 (KILOTON) 114
TABLE 40 NORTH AMERICA: MEDICAL ELASTOMERS MARKET, BY TYPE,
2021–2023 (USD MILLION) 115
TABLE 41 NORTH AMERICA: MEDICAL ELASTOMERS MARKET, BY TYPE,
2024–2029 (USD MILLION) 115
TABLE 42 NORTH AMERICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2021–2023 (KILOTON) 116
TABLE 43 NORTH AMERICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2024–2029 (KILOTON) 117
TABLE 44 NORTH AMERICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2021–2023 (USD MILLION) 118
TABLE 45 NORTH AMERICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2024–2029 (USD MILLION) 119
TABLE 46 NORTH AMERICA: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2021–2023 (KILOTON) 119
TABLE 47 NORTH AMERICA: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2024–2029 (KILOTON) 120
TABLE 48 NORTH AMERICA: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2021–2023 (USD MILLION) 120
TABLE 49 NORTH AMERICA: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2024–2029 (USD MILLION) 120
TABLE 50 US: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (KILOTON) 121
TABLE 51 US: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (KILOTON) 122
TABLE 52 US: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2021–2023 (USD MILLION) 123
TABLE 53 US: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2024–2029 (USD MILLION) 124
TABLE 54 CANADA: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2021–2023 (KILOTON) 125
TABLE 55 CANADA: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2024–2029 (KILOTON) 126
TABLE 56 CANADA: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2021–2023 (USD MILLION) 127
TABLE 57 CANADA: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2024–2029 (USD MILLION) 128
TABLE 58 MEXICO: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2021–2023 (KILOTON) 129
TABLE 59 MEXICO: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2024–2029 (KILOTON) 130
TABLE 60 MEXICO: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2021–2023 (USD MILLION) 131
TABLE 61 MEXICO: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2024–2029 (USD MILLION) 132
TABLE 62 ASIA PACIFIC: MARKET SHARES OF DIFFERENT TYPES OF MEDICAL ELASTOMERS, BY APPLICATION, 2023 133
TABLE 63 ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY COUNTRY,
2021–2023 (KILOTON) 134
TABLE 64 ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY COUNTRY,
2024–2029 (KILOTON) 134
TABLE 65 ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY COUNTRY,
2021–2023 (USD MILLION) 134
TABLE 66 ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY COUNTRY,
2024–2029 (USD MILLION) 135
TABLE 67 ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY TYPE, 2021–2023 (KILOTON) 135
TABLE 68 ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY TYPE, 2024–2029 (KILOTON) 136
TABLE 69 ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY TYPE,
2021–2023 (USD MILLION) 136
TABLE 70 ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY TYPE,
2024–2029 (USD MILLION) 137
TABLE 71 ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2021–2023 (KILOTON) 137
TABLE 72 ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2024–2029 (KILOTON) 138
TABLE 73 ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2021–2023 (USD MILLION) 139
TABLE 74 ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2024–2029 (USD MILLION) 140
TABLE 75 ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY,
2021–2023 (KILOTON) 140
TABLE 76 ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY,
2024–2029 (KILOTON) 141
TABLE 77 ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY,
2021–2023 (USD MILLION) 141
TABLE 78 ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY,
2024–2029 (USD MILLION) 141
TABLE 79 CHINA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (KILOTON) 142
TABLE 80 CHINA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (KILOTON) 143
TABLE 81 CHINA: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2021–2023 (USD MILLION) 144
TABLE 82 CHINA: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2024–2029 (USD MILLION) 145
TABLE 83 JAPAN: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (KILOTON) 146
TABLE 84 JAPAN: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (KILOTON) 147
TABLE 85 JAPAN: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2021–2023 (USD MILLION) 148
TABLE 86 JAPAN: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2024–2029 (USD MILLION) 149
TABLE 87 INDIA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (KILOTON) 150
TABLE 88 INDIA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (KILOTON) 151
TABLE 89 INDIA: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2021–2023 (USD MILLION) 152
TABLE 90 INDIA: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2024–2029 (USD MILLION) 153
TABLE 91 SOUTH KOREA: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2021–2023 (KILOTON) 154
TABLE 92 SOUTH KOREA: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2024–2029 (KILOTON) 155
TABLE 93 SOUTH KOREA: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2021–2023 (USD MILLION) 156
TABLE 94 SOUTH KOREA: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2024–2029 (USD MILLION) 157
TABLE 95 INDONESIA: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2021–2023 (KILOTON) 158
TABLE 96 INDONESIA: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2024–2029 (KILOTON) 159
TABLE 97 INDONESIA: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2021–2023 (USD MILLION) 160
TABLE 98 INDONESIA: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2024–2029 (USD MILLION) 161
TABLE 99 REST OF ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2021–2023 (KILOTON) 162
TABLE 100 REST OF ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2024–2029 (KILOTON) 163
TABLE 101 REST OF ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2021–2023 (USD MILLION) 164
TABLE 102 REST OF ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2024–2029 (USD MILLION) 165
TABLE 103 EUROPE: MARKET SHARES OF DIFFERENT TYPES OF MEDICAL ELASTOMERS,
BY APPLICATION, 2023 167
TABLE 104 EUROPE: MEDICAL ELASTOMERS MARKET, BY COUNTRY, 2021–2023 (KILOTON) 167
TABLE 105 EUROPE: MEDICAL ELASTOMERS MARKET, BY COUNTRY, 2024–2029 (KILOTON) 167
TABLE 106 EUROPE: MEDICAL ELASTOMERS MARKET, BY COUNTRY,
2021–2023 (USD MILLION) 168
TABLE 107 EUROPE: MEDICAL ELASTOMERS MARKET, BY COUNTRY,
2024–2029 (USD MILLION) 168
TABLE 108 EUROPE: MEDICAL ELASTOMERS MARKET, BY TYPE, 2021–2023 (KILOTON) 168
TABLE 109 EUROPE: MEDICAL ELASTOMERS MARKET, BY TYPE, 2024–2029 (KILOTON) 169
TABLE 110 EUROPE: MEDICAL ELASTOMERS MARKET, BY TYPE, 2021–2023 (USD MILLION) 169
TABLE 111 EUROPE: MEDICAL ELASTOMERS MARKET, BY TYPE, 2024–2029 (USD MILLION) 170
TABLE 112 EUROPE: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2021–2023 (KILOTON) 170
TABLE 113 EUROPE: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2024–2029 (KILOTON) 171
TABLE 114 EUROPE: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2021–2023 (USD MILLION) 172
TABLE 115 EUROPE: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2024–2029 (USD MILLION) 173
TABLE 116 EUROPE: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY,
2021–2023 (KILOTON) 173
TABLE 117 EUROPE: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY,
2024–2029 (KILOTON) 174
TABLE 118 EUROPE: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY,
2021–2023 (USD MILLION) 174
TABLE 119 EUROPE: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY,
2024–2029 (USD MILLION) 174
TABLE 120 GERMANY: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2021–2023 (KILOTON) 175
TABLE 121 GERMANY: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2024–2029 (KILOTON) 176
TABLE 122 GERMANY: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2021–2023 (USD MILLION) 177
TABLE 123 GERMANY: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2024–2029 (USD MILLION) 178
TABLE 124 UK: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (KILOTON) 179
TABLE 125 UK: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (KILOTON) 180
TABLE 126 UK: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2021–2023 (USD MILLION) 181
TABLE 127 UK: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2024–2029 (USD MILLION) 182
TABLE 128 FRANCE: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2021–2023 (KILOTON) 183
TABLE 129 FRANCE: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2024–2029 (KILOTON) 184
TABLE 130 FRANCE: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2021–2023 (USD MILLION) 185
TABLE 131 FRANCE: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2024–2029 (USD MILLION) 186
TABLE 132 ITALY: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (KILOTON) 187
TABLE 133 ITALY: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (KILOTON) 188
TABLE 134 ITALY: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2021–2023 (USD MILLION) 189
TABLE 135 ITALY: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2024–2029 (USD MILLION) 190
TABLE 136 SPAIN: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (KILOTON) 191
TABLE 137 SPAIN: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (KILOTON) 192
TABLE 138 SPAIN: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2021–2023 (USD MILLION) 193
TABLE 139 SPAIN: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2024–2029 (USD MILLION) 194
TABLE 140 REST OF EUROPE: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2021–2023 (KILOTON) 195
TABLE 141 REST OF EUROPE: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2024–2029 (KILOTON) 196
TABLE 142 REST OF EUROPE: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2021–2023 (USD MILLION) 197
TABLE 143 REST OF EUROPE: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2024–2029 (USD MILLION) 198
TABLE 144 MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET, BY COUNTRY,
2021–2023 (KILOTON) 199
TABLE 145 MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET, BY COUNTRY,
2024–2029 (KILOTON) 199
TABLE 146 MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET, BY COUNTRY,
2021–2023 (USD MILLION) 199
TABLE 147 MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET, BY COUNTRY,
2024–2029 (USD MILLION) 200
TABLE 148 MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET, BY TYPE,
2021–2023 (KILOTON) 200
TABLE 149 MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET, BY TYPE,
2024–2029 (KILOTON) 201
TABLE 150 MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET, BY TYPE,
2021–2023 (USD MILLION) 201
TABLE 151 MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET, BY TYPE,
2024–2029 (USD MILLION) 202
TABLE 152 MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (KILOTON) 202
TABLE 153 MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (KILOTON) 203
TABLE 154 MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 204
TABLE 155 MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 205
TABLE 156 MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2021–2023 (KILOTON) 205
TABLE 157 MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2024–2029 (KILOTON) 206
TABLE 158 MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2021–2023 (USD MILLION) 206
TABLE 159 MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2024–2029 (USD MILLION) 206
TABLE 160 SAUDI ARABIA: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2021–2023 (KILOTON) 208
TABLE 161 SAUDI ARABIA: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2024–2029 (KILOTON) 209
TABLE 162 SAUDI ARABIA: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2021–2023 (USD MILLION) 210
TABLE 163 SAUDI ARABIA: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2024–2029 (USD MILLION) 211
TABLE 164 REST OF GCC COUNTRIES: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (KILOTON) 212
TABLE 165 REST OF GCC COUNTRIES: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (KILOTON) 213
TABLE 166 REST OF GCC COUNTRIES: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 214
TABLE 167 REST OF GCC COUNTRIES: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 215
TABLE 168 SOUTH AFRICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2021–2023 (KILOTON) 216
TABLE 169 SOUTH AFRICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2024–2029 (KILOTON) 217
TABLE 170 SOUTH AFRICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2021–2023 (USD MILLION) 218
TABLE 171 SOUTH AFRICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2024–2029 (USD MILLION) 219
TABLE 172 REST OF MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET,
BY APPLICATION, 2021–2023 (KILOTON) 220
TABLE 173 REST OF MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET,
BY APPLICATION, 2024–2029 (KILOTON) 221
TABLE 174 REST OF MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET,
BY APPLICATION, 2021–2023 (USD MILLION) 222
TABLE 175 REST OF MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET,
BY APPLICATION, 2024–2029 (USD MILLION) 223
TABLE 176 SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY COUNTRY,
2021–2023 (KILOTON) 223
TABLE 177 SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY COUNTRY,
2024–2029 (KILOTON) 224
TABLE 178 SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY COUNTRY,
2021–2023 (USD MILLION) 224
TABLE 179 SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY COUNTRY,
2024–2029 (USD MILLION) 224
TABLE 180 SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY TYPE,
2021–2023 (KILOTON) 225
TABLE 181 SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY TYPE,
2024–2029 (KILOTON) 225
TABLE 182 SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY TYPE,
2021–2023 (USD MILLION) 226
TABLE 183 SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY TYPE,
2024–2029 (USD MILLION) 226
TABLE 184 SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2021–2023 (KILOTON) 227
TABLE 185 SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2024–2029 (KILOTON) 228
TABLE 186 SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2021–2023 (USD MILLION) 229
TABLE 187 SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2024–2029 (USD MILLION) 230
TABLE 188 SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2021–2023 (KILOTON) 230
TABLE 189 SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2024–2029 (KILOTON) 231
TABLE 190 SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2021–2023 (USD MILLION) 231
TABLE 191 SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2024–2029 (USD MILLION) 231
TABLE 192 BRAZIL: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2021–2023 (KILOTON) 232
TABLE 193 BRAZIL: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2024–2029 (KILOTON) 233
TABLE 194 BRAZIL: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2021–2023 (USD MILLION) 234
TABLE 195 BRAZIL: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2024–2029 (USD MILLION) 235
TABLE 196 ARGENTINA: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2021–2023 (KILOTON) 236
TABLE 197 ARGENTINA: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2024–2029 (KILOTON) 237
TABLE 198 ARGENTINA: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2021–2023 (USD MILLION) 238
TABLE 199 ARGENTINA: MEDICAL ELASTOMERS MARKET, BY APPLICATION,
2024–2029 (USD MILLION) 239
TABLE 200 REST OF SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (KILOTON) 240
TABLE 201 REST OF SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (KILOTON) 241
TABLE 202 REST OF SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 242
TABLE 203 REST OF SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 243
TABLE 204 MEDICAL ELASTOMERS MARKET: DEGREE OF COMPETITION 247
TABLE 205 NORTH AMERICA: MARKET SHARE ANALYSIS, BY MEDICAL TUBING, 2023 248
TABLE 206 NORTH AMERICA: MARKET SHARE ANALYSIS, BY CATHETER, 2023 248
TABLE 207 NORTH AMERICA: MARKET SHARE ANALYSIS, BY SYRINGE, 2023 248
TABLE 208 EUROPE: MARKET SHARE ANALYSIS, BY MEDICAL TUBING, 2023 249
TABLE 209 EUROPE: MARKET SHARE ANALYSIS, BY CATHETER, 2023 249
TABLE 210 EUROPE: MARKET SHARE ANALYSIS, BY SYRINGE, 2023 249
TABLE 211 ASIA PACIFIC: MARKET SHARE ANALYSIS, BY MEDICAL TUBING, 2023 250
TABLE 212 ASIA PACIFIC: MARKET SHARE ANALYSIS, BY CATHETER, 2023 250
TABLE 213 ASIA PACIFIC: MARKET SHARE ANALYSIS, BY SYRINGE, 2023 250
TABLE 214 MEDICAL ELASTOMERS MARKET: REGION FOOTPRINT 257
TABLE 215 MEDICAL ELASTOMERS MARKET: TECHNOLOGY FOOTPRINT 258
TABLE 216 MEDICAL ELASTOMERS MARKET: TYPE FOOTPRINT 259
TABLE 217 MEDICAL ELASTOMERS MARKET: APPLICATION FOOTPRINT 260
TABLE 218 MEDICAL ELASTOMERS MARKET: INDUSTRY FOOTPRINT 261
TABLE 219 MEDICAL ELASTOMERS MARKET: KEY STARTUPS/SMES 264
TABLE 220 MEDICAL ELASTOMERS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES 265
TABLE 221 MEDICAL ELASTOMERS MARKET: PRODUCT LAUNCHES,
JANUARY 2019–NOVEMBER 2024 267
TABLE 222 MEDICAL ELASTOMERS MARKET: DEALS, JANUARY 2019–NOVEMBER 2024 268
TABLE 223 MEDICAL ELASTOMERS MARKET: EXPANSIONS, JANUARY 2019–NOVEMBER 2024 269
TABLE 224 MEDICAL ELASTOMERS MARKET: OTHER DEVELOPMENTS,
JANUARY 2019– NOVEMBER 2024 270
TABLE 225 DOW: COMPANY OVERVIEW 271
TABLE 226 DOW.: PRODUCTS OFFERED 272
TABLE 227 DOW: OTHER DEVELOPMENTS, JANUARY 2019–NOVEMBER 2024 273
TABLE 228 EXXON MOBIL CORPORATION: COMPANY OVERVIEW 274
TABLE 229 EXXON MOBIL CORPORATION: PRODUCT OFFERINGS 276
TABLE 230 CELANESE CORPORATION: COMPANY OVERVIEW 277
TABLE 231 CELANESE CORPORATION: PRODUCTS OFFERED 278
TABLE 232 CELANESE CORPORATION: DEALS, JANUARY 2019–NOVEMBER 2024 279
TABLE 233 BASF: COMPANY OVERVIEW 281
TABLE 234 BASF: PRODUCTS OFFERED 282
TABLE 235 BASF: EXPANSIONS, JANUARY 2019–NOVEMBER 2024 283
TABLE 236 WACKER CHEMIE AG: COMPANY OVERVIEW 285
TABLE 237 WACKER CHEMIE AG: PRODUCTS OFFERED 286
TABLE 238 WACKER CHEMIE AG: PRODUCT LAUNCHES, JANUARY 2019–NOVEMBER 2024 287
TABLE 239 WACKER CHEMIE AG: EXPANSIONS, JANUARY 2019–NOVEMBER 2024 288
TABLE 240 EASTMAN CHEMICAL COMPANY: COMPANY OVERVIEW 290
TABLE 241 EASTMAN CHEMICAL COMPANY: PRODUCTS OFFERED 291
TABLE 242 SYENSQO: COMPANY OVERVIEW 293
TABLE 243 SYENSQO: PRODUCTS OFFERED 294
TABLE 244 SYENSQO: OTHER DEVELOPMENTS, JANUARY 2019–NOVEMBER 2024 295
TABLE 245 KURARAY CO., LTD: COMPANY OVERVIEW 297
TABLE 246 KURARAY CO., LTD: PRODUCT OFFERINGS 298
TABLE 247 MITSUBISHI CHEMICAL GROUP CORPORATION: COMPANY OVERVIEW 300
TABLE 248 MITSUBISHI CHEMICAL GROUP CORPORATION: PRODUCTS OFFERED 301
TABLE 249 MITSUBISHI CHEMICAL GROUP CORPORATION: OTHER DEVELOPMENTS,
JANUARY 2019–NOVEMBER 2024 302
TABLE 250 MITSUBISHI CHEMICAL GROUP CORPORATION: DEALS, JANUARY 2019– NOVEMBER 2024 303
TABLE 251 MOMENTIVE PERFORMANCE MATERIALS: COMPANY OVERVIEW 304
TABLE 252 MOMENTIVE PERFORMANCE MATERIALS: PRODUCTS OFFERED 304
TABLE 253 ENVALIOR: COMPANY OVERVIEW 306
TABLE 254 ENVALIOR: PRODUCTS OFFERED 306
TABLE 255 ZEON CORPORATION: COMPANY OVERVIEW 308
TABLE 256 ZEON CORPORATION: PRODUCTS OFFERED 309
TABLE 257 THE LUBRIZOL CORPORATION: COMPANY OVERVIEW 310
TABLE 258 THE LUBRIZOL CORPORATION: PRODUCTS OFFERED 310
TABLE 259 KRATON CORPORATION: COMPANY OVERVIEW 312
TABLE 260 FOSTER CORPORATION: COMPANY OVERVIEW 313
TABLE 261 BIOMERICS: COMPANY OVERVIEW 314
TABLE 262 RTP COMPANY: COMPANY OVERVIEW 315
TABLE 263 ROMAR ENGINEERING: COMPANY OVERVIEW 316
TABLE 264 THE RUBBER GROUP: COMPANY OVERVIEW 317
TABLE 265 KENT ELASTOMER PRODUCTS: COMPANY OVERVIEW 318
TABLE 266 RAUMEDIC AG: COMPANY OVERVIEW 319
TABLE 267 THE HYGENIC COMPANY, LLC: COMPANY OVERVIEW 320
TABLE 268 HEXAPOL AB: COMPANY OVERVIEW 321
TABLE 269 TEKNI-PLEX, INC: COMPANY OVERVIEW 322
TABLE 270 TRINSEO: COMPANY OVERVIEW 323
TABLE 271 TRELLEBORG AB: COMPANY OVERVIEW 324
TABLE 272 SAINT-GOBAIN: COMPANY OVERVIEW 325
LIST OF FIGURES
FIGURE 1 MEDICAL ELASTOMERS MARKET SEGMENTATION AND REGIONAL SCOPE 27
FIGURE 2 MEDICAL ELASTOMERS MARKET: RESEARCH DESIGN 30
FIGURE 3 MEDICAL ELASTOMERS MARKET: BOTTOM-UP APPROACH 34
FIGURE 4 MEDICAL ELASTOMERS MARKET: TOP-DOWN APPROACH 35
FIGURE 5 MARKET SIZE ESTIMATION: MEDICAL ELASTOMERS MARKET
(TOP-DOWN APPROACH) 35
FIGURE 6 DEMAND-SIDE FORECAST PROJECTIONS: DRIVERS 36
FIGURE 7 MEDICAL ELASTOMERS MARKET: DATA TRIANGULATION 37
FIGURE 8 THERMOSET ELASTOMERS TO DOMINATE MARKET DURING FORECAST PERIOD 41
FIGURE 9 MEDICAL TUBING APPLICATION TO DOMINATE MARKET DURING
FORECAST PERIOD 41
FIGURE 10 HOSPITALS & CLINICS TO DOMINATE MARKET DURING FORECAST PERIOD 42
FIGURE 11 ASIA PACIFIC TO BE FASTEST-GROWING REGION DURING FORECAST PERIOD 43
FIGURE 12 GROWING DEMAND FOR MEDICAL DEVICES FROM HEALTHCARE SECTOR
TO DRIVE MARKET 44
FIGURE 13 THERMOPLASTIC ELASTOMERS TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 44
FIGURE 14 IMPLANTS SEGMENT TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 45
FIGURE 15 HOSPITALS & CLINICS TO BE LARGEST END-USE INDUSTRY FOR
MEDICAL ELASTOMERS 45
FIGURE 16 INDIA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 46
FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN MEDICAL ELASTOMERS MARKET 47
FIGURE 18 MEDICAL ELASTOMERS MARKET: PORTER’S FIVE FORCES ANALYSIS 51
FIGURE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR
TOP THREE END-USE INDUSTRIES 54
FIGURE 20 KEY BUYING CRITERIA FOR TOP-THREE END-USE INDUSTRIES 55
FIGURE 22 MEDICAL ELASTOMERS MARKET: ECOSYSTEM 61
FIGURE 23 MEDICAL ELASTOMERS MARKET: TRENDS AND DISRUPTIONS IMPACTING CUSTOMER BUSINESS 69
FIGURE 24 IMPORT DATA FOR HS-CODE 391000-COMPLIANT PRODUCTS, BY COUNTRY
2019–2023 (USD THOUSAND) 70
FIGURE 25 EXPORT DATA FOR HS-CODE 391000-COMPLIANT PRODUCTS, BY COUNTRY
2019–2023 (USD THOUSAND) 71
FIGURE 26 IMPORT DATA FOR HS-CODE 400270-COMPLIANT PRODUCTS, BY COUNTRY
2019–2023 (USD THOUSAND) 72
FIGURE 27 EXPORT DATA FOR HS CODE 400270–COMPLIANT PRODUCTS, BY COUNTRY 2019–2023 (USD THOUSAND) 73
FIGURE 28 AVERAGE SELLING PRICE TREND OF MEDICAL ELASTOMERS, BY REGION (USD/KG), 2021–2023 75
FIGURE 29 AVERAGE SELLING PRICE TREND OF MEDICAL ELASTOMERS, BY APPLICATION (USD/KG), 2021–2023 76
FIGURE 30 AVERAGE SELLING PRICE TREND OF MEDICAL ELASTOMERS, BY END-USE INDUSTRY (USD/KG), 2021–2023 76
FIGURE 31 INVESTMENT AND FUNDING SCENARIO, 2021–2023 (USD MILLION) 77
FIGURE 32 PATENTS APPLIED AND GRANTED, 2014–2023 78
FIGURE 33 LEGAL STATUS OF PATENTS (2013–2024) 79
FIGURE 34 TOP JURISDICTIONS 80
FIGURE 35 HOSPITALS & CLINICS SEGMENT TO BE LARGEST END-USE
INDUSTRY DURING FORECAST PERIOD 87
FIGURE 36 MEDICAL TUBING TO BE LARGEST APPLICATION SEGMENT DURING
FORECAST PERIOD 92
FIGURE 37 THERMOSET ELASTOMERS TO DOMINATE MARKET DURING FORECAST PERIOD 102
FIGURE 38 ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 109
FIGURE 39 NORTH AMERICA: MEDICAL ELASTOMERS MARKET SNAPSHOT 112
FIGURE 40 ASIA PACIFIC: MEDICAL ELASTOMERS MARKET SNAPSHOT 133
FIGURE 41 EUROPE: MEDICAL ELASTOMERS MARKET SNAPSHOT 166
FIGURE 42 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MEDICAL ELASTOMERS MARKET BETWEEN JANUARY 2019 AND NOVEMBER 2024 245
FIGURE 43 REVENUE ANALYSIS OF KEY PLAYERS IN MEDICAL ELASTOMERS
MARKET, 2021–2023 246
FIGURE 44 MEDICAL ELASTOMERS MARKET SHARE OF KEY PLAYERS, 2023 247
FIGURE 45 VALUATION OF LEADING COMPANIES IN MEDICAL ELASTOMERS MARKET, 2023 252
FIGURE 46 FINANCIAL METRICS OF LEADING COMPANIES IN MEDICAL
ELASTOMERS MARKET, 2023 252
FIGURE 47 MEDICAL ELASTOMERS MARKET: COMPANY EVALUATION
MATRIX (KEY PLAYERS), 2023 255
FIGURE 48 MEDICAL ELASTOMERS MARKET: OVERALL COMPANY FOOTPRINT 256
FIGURE 49 MEDICAL ELASTOMERS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 263
FIGURE 50 DOW: COMPANY SNAPSHOT 272
FIGURE 51 EXXON MOBIL CORPORATION: COMPANY SNAPSHOT 275
FIGURE 52 CELANESE CORPORATION: COMPANY SNAPSHOT 278
FIGURE 53 BASF: COMPANY SNAPSHOT 282
FIGURE 54 WACKER CHEMIE AG: COMPANY SNAPSHOT 286
FIGURE 55 EASTMAN CHEMICAL COMPANY: COMPANY SNAPSHOT 290
FIGURE 56 SYENSQO: COMPANY SNAPSHOT 294
FIGURE 57 KURARAY CO., LTD: COMPANY SNAPSHOT 298
FIGURE 58 MITSUBISHI CHEMICAL GROUP CORPORATION: COMPANY SNAPSHOT 301
FIGURE 59 ZEON CORPORATION: COMPANY SNAPSHOT 308
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11